Abstract PR018: IMA203 TCR-T targeting PRAME demonstrates potent anti-tumor activity in patients with different types of metastatic solid tumorsMartin Wermke, Jason J. Luke, Steffen Walter et al.|Molecular Cancer Therapeutics|2023Cited by 16